Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update

In March 2020, when coronavirus disease 2019 (COVID-19) was just beginning to spread around the world, we presented the potential benefits and controversies of anti-inflammatory therapy in COVID-19 patients based on the limited experience and proposed some types of anti-inflammatory drugs with poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen, Qin, Chenman, Fei, Yunyun, Shen, Min, Zhou, Yangzhong, Zhang, Yan, Zeng, Xiaofeng, Zhang, Shuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040414/
https://www.ncbi.nlm.nih.gov/pubmed/35477027
http://dx.doi.org/10.1016/j.clim.2022.109022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040414/
https://www.ncbi.nlm.nih.gov/pubmed/35477027
http://dx.doi.org/10.1016/j.clim.2022.109022

Ejemplares similares